PolyCore Therapeutics

BiotechnologySeedPhiladelphia, USpolycoretherapeutics.com

Latest round

Seed

Last raised

Apr 2022

Total raised

$5M

Investors

2

About PolyCore Therapeutics

Based in Pennsylvania, US, and founded in 2014 by Jim Harris, PolyCore Therapeutics, LLC operates as a biopharmaceutical company that develops treatments for patients with neurodegenerative diseases. The firm's product pipeline includes PCT-3012, a novel small molecule for the treatment of Parkinson’s motor symptoms and dyskinesia in patients with early- to mid-stage Parkinson’s Disease. In addition, the company is looking into PCT-3012's potential uses for the treatment of ADHD, Huntington’s disease, and other dyskinesia and cognitive disorders.

Who invested in PolyCore Therapeutics

2 investors across 2 rounds

See all investors in PolyCore Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Apr 11, 2022

    Amount

    $4.7M

    Investors

    Locked

  2. Seed

    Jun 22, 2016

    Amount

    $0.3M

    Investors

    Locked

Questions about PolyCore Therapeutics

Who invested in PolyCore Therapeutics?

PolyCore Therapeutics has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has PolyCore Therapeutics raised?

PolyCore Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did PolyCore Therapeutics last raise money?

PolyCore Therapeutics's most recent round on record is a Seed, in Apr 2022.

What does PolyCore Therapeutics do?

Based in Pennsylvania, US, and founded in 2014 by Jim Harris, PolyCore Therapeutics, LLC operates as a biopharmaceutical company that develops treatments for patients with neurodegenerative diseases.

Where is PolyCore Therapeutics headquartered?

PolyCore Therapeutics is headquartered in Philadelphia, US.

Which VCs invest in companies like PolyCore Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at PolyCore Therapeutics's stage. Their profiles are linked below.

Raising like PolyCore Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.